Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin

A Bordetella pertussis strain lacking 2 acellular vaccine immunogens, pertussis toxin and pertactin, was isolated from an unvaccinated infant in New York State in 2013. Comparison with a French strain that was pertussis toxin–deficient, pertactin wild-type showed that the strains carry the same 28-kb deletion in similar genomes.

[1]  Sarah A. Meyer,et al.  Molecular Epidemiology of the Pertussis Epidemic in Washington State in 2012 , 2014, Journal of Clinical Microbiology.

[2]  M. Quail,et al.  Global Population Structure and Evolution of Bordetella pertussis and Their Relationship with Vaccination , 2014, mBio.

[3]  N. Perna,et al.  progressiveMauve: Multiple Genome Alignment with Gene Gain, Loss and Rearrangement , 2010, PloS one.

[4]  G. Pugliese,et al.  Severe Streptococcus pyogenes Infections, United Kingdom, 2003–2004 , 2008, Emerging infectious diseases.

[5]  C. Kenyon,et al.  Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  J. Pennings,et al.  Correction: Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: identification of genes absent from epidemic strains , 2010, BMC Genomics.

[7]  M. Tondella,et al.  Novel Multitarget Real-Time PCR Assay for Rapid Detection of Bordetella Species in Clinical Specimens , 2011, Journal of Clinical Microbiology.

[8]  T. Skoff,et al.  Tracking Pertussis and Evaluating Control Measures through Enhanced Pertussis Surveillance, Emerging Infections Program, United States , 2015, Emerging infectious diseases.

[9]  H. Sato,et al.  Effect of heptakis (2,6-O-dimethyl) beta-cyclodextrin on the production of pertussis toxin by Bordetella pertussis , 1983, Infection and immunity.

[10]  T. Skoff,et al.  Population Diversity among Bordetella pertussis Isolates, United States, 1935–2009 , 2012, Emerging infectious diseases.

[11]  T. Clark,et al.  Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. , 2012, JAMA.

[12]  W. Probert,et al.  Identification and Evaluation of New Target Sequences for Specific Detection of Bordetella pertussis by Real-Time PCR , 2008, Journal of Clinical Microbiology.

[13]  B. Barrell,et al.  Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica , 2003, Nature Genetics.

[14]  M. Tondella,et al.  Prevalence and Molecular Characterization of Pertactin-Deficient Bordetella pertussis in the United States , 2013, Clinical and Vaccine Immunology.

[15]  R. Weyant,et al.  Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999. , 2002, Emerging infectious diseases.

[16]  G. Dore,et al.  First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin. , 2009, Vaccine.